نتایج جستجو برای: fgfr2 gene

تعداد نتایج: 1142053  

Journal: :American journal of epidemiology 2011
Wang-Hong Xu Xiao-Ou Shu Jirong Long Wei Lu Qiuyin Cai Ying Zheng Yong-Bing Xiang Qi Dai Gen-Ming Zhao Kai Gu Ping-Ping Bao Yu-Tang Gao Wei Zheng

The fibroblast growth factor receptor 2 gene (FGFR2) has been associated with the risk of breast cancer in multiple ethnic populations, and its effect has been suggested to be hormone-dependent. A large, 2-stage, population-based case-control study was conducted in urban Shanghai, China, during the periods of 1996-1998 and 2002-2005. Exposure and genotyping information from 2,073 patients with ...

Journal: :The Journal of biological chemistry 2006
Nan E Hatch Mark Hudson Marianne L Seto Michael L Cunningham Mark Bothwell

Fibroblast growth factors (FGFs) and their receptors (FGFRs) are known to play a critical role in a variety of fundamental processes, including wound healing, angiogenesis, and development of multiple organ systems. Mutations in the FGFR gene family have been linked to a series of syndromes (the craniosynostosis syndromes) whose primary phenotype involves aberrant development of the craniofacia...

Journal: :Human molecular genetics 2009
Miriam S Udler Kerstin B Meyer Karen A Pooley Eric Karlins Jeffery P Struewing Jinghui Zhang David R Doody Stewart MacArthur Jonathan Tyrer Paul D Pharoah Robert Luben Leslie Bernstein Laurence N Kolonel Brian E Henderson Loic Le Marchand Giske Ursin Michael F Press Paul Brennan Suleeporn Sangrajrang Valerie Gaborieau Fabrice Odefrey Chen-Yang Shen Pei-Ei Wu Hui-Chun Wang Daehee Kang Keun-Young Yoo Dong-Young Noh Sei-Hyun Ahn Bruce A J Ponder Christopher A Haiman Kathleen E Malone Alison M Dunning Elaine A Ostrander Douglas F Easton

Genome-wide association studies have identified FGFR2 as a breast cancer (BC) susceptibility gene in populations of European and Asian descent, but a causative variant has not yet been conclusively identified. We hypothesized that the weaker linkage disequilibrium across this associated region in populations of African ancestry might help refine the set of candidate-causal single nucleotide pol...

2014
Nuria Eritja M onica Domingo Maria Alba Dosil Cristina Mirantes Maria Santacana Joan Valls Antonio Llombart-Cussac Xavier Matias-Guiu Xavier Dolcet

Mutations in fibroblast growth factor receptor 2 (FGFR2) have been recently described as a molecularspecific feature in endometrial carcinomas and the presence of activated FGFR2 mutations is associated with poor prognosis. For that reason, inhibition of FGFR2 could be a therapeutic target in the treatment of endometriod carcinomas. In this work, we investigated the antitumoral activity of dovi...

2015
Jinjia Chang Shanshan Wang Zhe Zhang Xinyang Liu Zheng Wu Ruixuan Geng Xiaoxiao Ge Congqi Dai Rujiao Liu Qunling Zhang Wenhua Li Jin Li

Fibroblast growth factor receptor 2 (FGFR2)-targeted therapy has attracted considerable attention as novel anticancer agents in gastric cancer (GC). However, intrinsic or acquired drug resistance has emerged as a major challenge to their clinical use. In this study, we demonstrated that several receptor tyrosine kinase (RTK), including EGFR, HER3 and MET, activations contributed to AZD4547 (a s...

2014
Mitesh J. Borad Mia D. Champion Jan B. Egan Winnie S. Liang Rafael Fonseca Alan H. Bryce Ann E. McCullough Michael T. Barrett Katherine Hunt Maitray D. Patel Scott W. Young Joseph M. Collins Alvin C. Silva Rachel M. Condjella Matthew Block Robert R. McWilliams Konstantinos N. Lazaridis Eric W. Klee Keith C. Bible Pamela Harris Gavin R. Oliver Jaysheel D. Bhavsar Asha A. Nair Sumit Middha Yan Asmann Jean-Pierre Kocher Kimberly Schahl Benjamin R. Kipp Emily G. Barr Fritcher Angela Baker Jessica Aldrich Ahmet Kurdoglu Tyler Izatt Alexis Christoforides Irene Cherni Sara Nasser Rebecca Reiman Lori Phillips Jackie McDonald Jonathan Adkins Stephen D. Mastrian Pamela Placek Aprill T. Watanabe Janine LoBello Haiyong Han Daniel Von Hoff David W. Craig A. Keith Stewart John D. Carpten

Advanced cholangiocarcinoma continues to harbor a difficult prognosis and therapeutic options have been limited. During the course of a clinical trial of whole genomic sequencing seeking druggable targets, we examined six patients with advanced cholangiocarcinoma. Integrated genome-wide and whole transcriptome sequence analyses were performed on tumors from six patients with advanced, sporadic ...

2014
Florian Meier Florian Giesert Sabit Delic Theresa Faus-Kessler Friederike Matheus Antonio Simeone Sabine M. Hölter Ralf Kühn Daniela M. Vogt. Weisenhorn Wolfgang Wurst Nilima Prakash

The normal cellular organization and layering of the vertebrate cerebellum is established during embryonic and early postnatal development by the interplay of a complex array of genetic and signaling pathways. Disruption of these processes and of the proper layering of the cerebellum usually leads to ataxic behaviors. Here, we analyzed the relative contribution of Fibroblast growth factor recep...

2017
Emma Peskett Samin Kumar William Baird Janhvi Jaiswal Ming Li Priyanca Patel Jonathan A Britto Erwin Pauws

Syndromic craniosynostosis caused by mutations in FGFR2 is characterised by developmental pathology in both endochondral and membranous skeletogenesis. Detailed phenotypic characterisation of features in the membranous calvarium, the endochondral cranial base and other structures in the axial and appendicular skeleton has not been performed at embryonic stages. We investigated bone development ...

Journal: :Molecular pharmacology 2009
Lindsay Marek Kathryn E Ware Alexa Fritzsche Paula Hercule Wallace R Helton Jennifer E Smith Lee A McDermott Christopher D Coldren Raphael A Nemenoff Daniel T Merrick Barbara A Helfrich Paul A Bunn Lynn E Heasley

Despite widespread expression of epidermal growth factor (EGF) receptors (EGFRs) and EGF family ligands in non-small-cell lung cancer (NSCLC), EGFR-specific tyrosine kinase inhibitors (TKIs) such as gefitinib exhibit limited activity in this cancer. We propose that autocrine growth signaling pathways distinct from EGFR are active in NSCLC cells. To this end, gene expression profiling revealed f...

2015
Lilian Torres Gualberto Hernández Alejandro Barrera Sandra Ospina Rolando Prada

INTRODUCTION Apert syndrome (AS) is a craniosynostosis condition caused by mutations in the Fibroblast Growth Factor Receptor 2 (FGFR2) gene. Clinical features include cutaneous and osseous symmetric syndactily in hands and feet, with variable presentations in bones, brain, skin and other internal organs. METHODS Members of two families with an index case of Apert Syndrome were assessed to de...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید